The Resource Design and manufacture of pharmaceutical tablets, Reynir Eyjolfsson

Design and manufacture of pharmaceutical tablets, Reynir Eyjolfsson

Label
Design and manufacture of pharmaceutical tablets
Title
Design and manufacture of pharmaceutical tablets
Statement of responsibility
Reynir Eyjolfsson
Creator
Author
Subject
Language
eng
Summary
Design and Manufacture of Pharmaceutical Tablets offers real world solutions and outcomes of formulation and processing challenges of pharmaceutical tablets. This book includes numerous practical examples related to actual formulations that have been validated and marketed and covers important data in the areas of stability, dissolution, bioavailibity and processing. It provides important background and theoretical information on design and manufacturing and includes a full section dedicated to design experimental methodology and statistics. In addition, this book offers a a general discuss
Cataloging source
YDXCP
Dewey number
615.1/9
Index
index present
LC call number
RS201.T2
LC item number
E95 2015
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
Label
Design and manufacture of pharmaceutical tablets, Reynir Eyjolfsson
Publication
Copyright
Bibliography note
Includes bibliographical references at the end of each chapters and index
http://library.link/vocab/branchCode
  • net
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • Cover; Title Page; Copyright Page; Dedication; Contents; Preface; Abbreviations; Chapter One -- Introduction; 1.1 -- General considerations; 1.2 -- Particle sizes; 1.3 -- Excipients; 1.3.1 -- Ac-Di-Sol SD-711; 1.3.2 -- Aerosil 200; 1.3.3 -- Avicel PH-102; 1.3.4 -- Compactrol; 1.3.5 -- Corn starch; 1.3.6 -- Di-Tab; 1.3.7 -- Eudragit RS PO; 1.3.8 -- Magnesium stearate 5712; 1.3.9 -- Mannitol 60; 1.3.10 -- Methocel K4M Premium; 1.3.11 -- Methocel K100M Premium; 1.3.12 -- Methocel K100LV Premium; 1.3.13 -- Pharmatose 150M; 1.3.14 -- Polyplasdone XL-10; 1.3.15 -- Povidone; 1.3.16 -- Primojel; 1.3.17 -- Pruv
  • 1.3.18 -- Sodium bicarbonate1.3.19 -- Starch 1500; 1.3.20 -- Stearic acid 2236; 1.3.21 -- Sterotex K; 1.3.22 -- Tablettose 80; 1.3.23 -- Talc; 1.4 -- Equipment; 1.5 -- Mixing of pharmaceutical powders; 1.6 -- Design of experiments; 1.6.1 -- Introduction to statistical design of experiments -- the two-level factorial; 1.6.1.1 -- Introduction; 1.6.1.2 -- Designed experiments; 1.6.1.3 -- Basic considerations; 1.6.1.4 -- Two-level factorials; 1.6.1.5 -- Two-level fractional factorials; 1.6.2 -- Response surface methodology (RSM); 1.6.2.1 -- Introduction; 1.6.2.2 -- RSM and a sieving process variable study
  • 1.6.2.3 -- RSM investigation of the properties of a three-component tablet formulationReferences; Chapter two -- Conventional-Release (CR) Tablets; 2.1 -- Low-dose tablet by direct compression (DC); 2.1.1 -- Properties of active pharmaceutical ingredient (API); 2.1.2 -- Design; 2.1.3 -- Manufacturing method; 2.1.4 -- Remarks; 2.2 -- High-dose tablet by direct compression; 2.2.1 -- Properties of active pharmaceutical ingredient; 2.2.2 -- Design; 2.2.3 -- Manufacturing method; 2.2.4 -- Remarks; 2.3 -- Low-solubility API, low-dose tablet by wet granulation (WG)
  • 2.3.1 -- Properties of active pharmaceutical ingredient2.3.2 -- Design; 2.3.3 -- Manufacturing method; 2.3.4 -- Remarks; 2.4 -- Soluble API, low-dose tablet by wet granulation; 2.4.1 -- Properties of active pharmaceutical ingredient; 2.4.2 -- Design; 2.4.3 -- Manufacturing method; 2.4.4 -- Remarks; 2.5 -- Low-solubility API, high-dose tablet by wet granulation; 2.5.1 -- Properties of active pharmaceutical ingredient; 2.5.2 -- Design; 2.5.3 -- Manufacturing method; 2.5.4 -- Remarks; 2.6 -- Soluble API, high-dose tablet by wet granulation; 2.6.1 -- Properties of active pharmaceutical ingredient; 2.6.2 -- Design
  • 2.6.3 -- Manufacturing method2.6.4 -- Remarks; References; Chapter three -- Slow-Release (SR) Tablets; 3.1 -- Slow-release tablet using a lipophilic release control agent; 3.1.1 -- Properties of active pharmaceutical ingredient (API); 3.1.2 -- Design; 3.1.3 -- Manufacturing method; 3.1.4 -- Remarks; 3.2 -- Slow-release tablet using Eudragit and Methocel as release control agents; 3.2.1 -- Properties of active pharmaceutical ingredient; 3.2.2 -- Design; 3.2.3 -- Manufacturing method; 3.2.4 -- Remarks; 3.3 -- Slow-release tablet using a mixture of Methocels as release control agent
  • 3.3.1 -- Properties of active pharmaceutical ingredient
Control code
ocn899273378
Dimensions
unknown
Extent
1 online resource (xi, 55 pages)
Form of item
online
Isbn
9780128021828
Media category
computer
Media MARC source
rdamedia
Media type code
c
http://library.link/vocab/recordID
.b34526870
Specific material designation
remote
System control number
  • (OCoLC)899273378
  • ebl012802187X

Library Locations

    • Deakin University Library - Geelong Waurn Ponds CampusBorrow it
      75 Pigdons Road, Waurn Ponds, Victoria, 3216, AU
      -38.195656 144.304955
Processing Feedback ...